Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06650410Not ApplicableCompleted

Virtual Intervention for Vertebral frActure: a Pilot, Feasibility Study for a Multicentre Randomized Controlled Trial

Role: collaborator

NCT05125510Active Not Recruiting

The Canadian COVID-19 Prospective Cohort Study

Role: collaborator

NCT06970535Withdrawn

Breastmilk Composition and Microbial Profile in the Growth and Development of Healthy Term-born Infants

Role: collaborator

NCT06464471Not ApplicableRecruiting

Comprehensive Health Assessment for My Plan: Initial Implementation Study (CHAMP Implementation Study)

Role: collaborator

NCT02735707Phase 3Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Role: collaborator

NCT04114734Not ApplicableUnknown

Park Rx and Physical Activity Among Low-income Children

Role: collaborator

All 6 trials loaded